Inhibitor-resistant mutants of the HIV-1 aspartic protease.
DuPont Merck Virus Laboratory, Glenolden, PA 19036, USA.
B D
BD
Korant
D001381:Azepines; D003001:Cloning, Molecular; D004352:Drug Resistance, Microbial; D004926:Escherichia coli; D016333:HIV Protease / Q000235:genetics / Q000378:metabolism*; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D016296:Mutagenesis; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D014508:Urea / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology
D001381:Azepines; D017320:HIV Protease Inhibitors; D011994:Recombinant Proteins; D014508:Urea; D016333:HIV Protease; C085816:DMP 323